Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €2.76 EUR
Change Today +0.032 / 1.17%
Volume 200.0
S7Y On Other Exchanges
As of 1:55 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

solazyme inc (S7Y) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/3/14 - €6.22
52 Week Low
02/26/15 - €1.49
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SOLAZYME INC (S7Y)

solazyme inc (S7Y) Related Businessweek News

View More BusinessWeek News

solazyme inc (S7Y) Details

Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blendstocks for marine, motor vehicle, and jet fuels, as well as replacements for petrochemicals, oleochemicals, and functional fluids. It also provides fuels, including SoladieselBD and SoladieselRD for on-road applications; ultra-low sulfur diesel; and Solajet for aviation use. In addition, the company offers microalgae-based food ingredients consisting of Tailored oils and powdered oils; and powdered ingredients comprising AlgaVia whole algal flour, AlgaVia whole algal protein, AlgaVia lipid powder, and encapsulated oils. Additionally, it provides skin and personal care products under the Algenist brand name, which include concentrated reconstructing serum, an anti-aging serum; complete eye renewal balm; firming and lifting cream, an anti-aging moisturizing cream; advanced anti-aging repairing oil, a face oil formulation; and genius cream. The company was incorporated in 2003 and is headquartered in South San Francisco, California.

266 Employees
Last Reported Date: 03/6/15
Founded in 2003

solazyme inc (S7Y) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $560.0K
Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $410.4K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $335.0K
Chief Technology Officer
Total Annual Compensation: $370.8K
Strategic Advisor
Total Annual Compensation: $378.8K
Compensation as of Fiscal Year 2014.

solazyme inc (S7Y) Key Developments

Kahn Swick & Foti, LLC and KSF Partner File Securities Class Action Lawsuit Against Solazyme, Inc

Kahn Swick & Foti, LLC and KSF partner filed securities class action lawsuit against Solazyme, Inc. Solazyme and certain of its executives are charged with failing to disclose material information during the class period and in connection with the March 27, 2014 Offerings, violating federal securities laws. Solazyme allegedly made false statements and omissions about its construction progress, development and production capacity at its renewable oils production facility located in Moema, Brazil, failing to disclose that the Moema Facility was experiencing construction delays due to insufficient access to electricity and steam utility services, and that these challenges would prohibit the Moema Facility from scaling its capacity production as projected. On November 5, 2014, the truth regarding the Moema Project was revealed to investors, and the price of Solazyme’s shares plummeted by 58%.

Solazyme, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Solazyme, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenues of $11,740,000 against $15,939,000 a year ago. Loss from operations was $26,318,000 against $32,232,000 a year ago. Net loss was $37,171,000 against $42,917,000 a year ago. Basic and diluted net loss per share was $0.46 against $0.56 a year ago. Net loss (non-GAAP) was $31,717,000 against $32,874,000 a year ago. Net loss per share (non-GAAP) - basic and diluted was $0.40 against $0.43 a year ago. For the six months, the company reported total revenues of $24,345,000 against $28,330,000 a year ago. Loss from operations was $52,629,000 against $64,673,000 a year ago. Net loss was $71,836,000 against $77,598,000 a year ago. Basic and diluted net loss per share was $0.90 against $1.07 a year ago. Net loss (non-GAAP) was $61,250,000 against $63,402,000 a year ago. Net loss per share (non-GAAP) - basic and diluted was $0.77 against $0.87 a year ago. The year over year decline in Revenue was due to expected decreases in funded program revenue as well as in product revenue due to the timing of certain Algenist sales activities and slower than anticipated adoption rates for Encapso.

BASF and Solazyme, Inc Announces Launch the First Commercial Microalgae-Derived Betaine Surfactant

BASF and Solazyme, Inc. announced the launch of the first commercial surfactant derived from microalgae oil, a high performance algal betaine for use in home and personal care applications. Commercialized by BASF under the trade name Dehyton® AO 45, algal betaine is a betaine surfactant made from renewable microalgae oil. The new algal betaine is a high- performance alternative to amidopropyl betaine in products that require rich and gentle foam such as shampoos, liquid soaps, hand dishwashing liquids, and other applications. Amidopropyl betaines are amphoteric surfactants increasingly used in cosmetic, toiletry and home care applications due to their vast benefits and are known to have: good detergency, good foam properties and foam stabilization, hard water compatibility, mildness to skin and hair, ability to reduce irritation of anionic systems, viscosity building, conditioning effect, stability at a broad range of pH, and excellent biodegradability. Dehyton® AO 45 is produced with Solazyme AlgaPur™ Microalgae Oils. AlgaPur™ Oils are produced with Solazyme’s technology in a matter of days, using a highly controlled fermentation process to convert sugarcane into oils of the high purity and performance. AlgaPur™ Microalgae Oils are produced with low carbon, water and land use impact.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
S7Y:GR €2.76 EUR +0.032

S7Y Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amyris Inc $2.30 USD +0.11
Gevo Inc $2.14 USD +0.08
Wessanen €8.83 EUR -0.097
Pacific Ethanol Inc $7.14 USD -0.18
Renewable Energy Group Inc $9.46 USD +0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation S7Y Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.4x
Price/Book 12.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at